drugset / Trial / NCT01975298
A Study to Evaluate 2 Doses Of Oral Administration Of Laquinimod Compared to Interferon ß-1a Administered by Injection in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to assess the efficacy, safety, and tolerability of two doses of laquinimod compared to Avonex®
Timeline
- Start
- 2014-01
- Primary completion
- 2014-03
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Interferon beta-1a | Protein / enzyme biologic | 30 ug | Intramuscular |
| Subject | Laquinimod | Small molecule | 0.6 mg | Oral |
| Subject | Laquinimod | Small molecule | 1.2 mg | Oral |